Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

19 Jan 2010 07:00

RNS Number : 7493F
BrainJuicer Group PLC
19 January 2010
 



Press release 

19 January 2010

BrainJuicer Group PLC

("BrainJuicer" or "the Group" or "the Company")

Trading Update

Profitable growth

Leading international online market researcher, BrainJuicer Group PLC, today gives the following update on trading ahead of its Preliminary Results for the financial year ended 31 December 2009 which will be announced on 9 March 2010.

Highlights:

 

·;  
Results expected to be in line with market expectations; profitable growth continues despite difficult market conditions and significant investment in product development, operations and technology
·;
Revenue up around 26% to approximately £11.7 million (2008: £9.3 million)
·;
Operating profit up by more than 25% to over £1.6 million (2008: £1.29 million)
·;
Strong financial position with cash up to around £2.3 million at 31 December 2009 (30 June 2009: £1.2m) and no debt
·;
Innovative ‘Juicy’ products grew 65% to over 60% of turnover [2008: 46%]
·;
Working with 11 of the world’s top 20 buyers of market research [9 in 2008]
·;
Both new offices, Switzerland and Germany achieved profitability in their first 18 months

BrainJuicer's reputation for innovation grew further in 2009 with revenue from the Group's strategically important 'Juicy' products making significant gains and now accounting for over 60% of the Group's revenue (2008: 46%). These products are being sold to some of the world's largest buyers of market research. In 2009 the Company's clients included 11 of the world's top 20 buyers of market research, up from 9 in 2008, and revenue from these clients grew by over 70%. Client satisfaction remains high with repeat business at around 80%.

Revenue increase was driven by continued strong progress in the US, growing at around 60%, and by very encouraging contributions from the new offices in Switzerland and Germany. The Company's  UK business recovered after a slow start to the year (revenue for the full year was around 2% lower), and Dutch revenue grew about 10%. Overall the Group achieved approximately 26% revenue growth (21% on a constant currency basis).

Operating profit is up by more than 25whilst having at the same time invested more than ever before in developing and validating productsin back-office operations and in the Company's software  platform. We believe this investment will drive future growth.

The Group has reached an agreement to acquire High Level Research Inc., its Canadian licencee, for a nominal sum This will be managed as a regional office within our North American business.

John KearonCEO of BrainJuicer, commented: "To have grown so strongly in a year when spending on market research seems to have declined for the first time in 25 years is a tremendous achievement and testament to the attraction of our innovative 'Juicy' products, expanded geographic footprint and talented researchers to our major multinational client base. Despite the dire economic conditions, we have continued to make significant investments.  Whilst many of the largest research agencies have apparently declined and retrenched during 2009, we continued to invest heavily in new and existing 'Juicy' products, enhancing the efficiency and scalability of our technology platform and expanding our geographic footprint. These investments will, we believe, enable us to secure the global and regional mandates which we need to fulfil our longer term ambitions.

"The Board is confident that in 2010 we can continue to grow our business through  further product  innovation and increasing our market share with major multinational customers."

An analyst presentation, given by John KearonCEO, and James Geddes, CFO, will be held at 9.30am on 9 March 2010 at Abchurch's office, 16th Floor, 125 Old Broad StreetLondonEC2N 1AR.

- Ends -

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0) 20 7043 1000

John Kearon, Chief Executive Officer

john.kearon@brainjuicer.com

James Geddes, Chief Financial Officer

james.geddes@brainjuicer.com

Canaccord Adams

Tel: +44 (0) 20 7050 6500

Mark Williams / Henry Fitzgerald-O'Connor

www.canaccordadams.com

Media enquiries:

Abchurch Communications

Heather Salmond / Joanne Shears

Tel: +44 (0) 20 7398 7709

joanne.shears@abchurch-group.com

www.abchurch-group.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWOWRROAAAAR
Date   Source Headline
5th Sep 20197:00 amRNSGrant of Options
1st Aug 20197:00 amRNSResult of AGM
28th Jun 201912:30 pmRNSAnnual Report and Notice of AGM
12th Jun 20197:00 amRNSHolding(s) in Company
6th Jun 20197:00 amRNSDividend Declaration
6th Jun 20197:00 amRNSFinancial results to 31 March 2019
18th Apr 20197:00 amRNSGrant of Options
15th Apr 20197:00 amRNSTrading Update
19th Nov 20187:00 amRNSDirector/PDMR Shareholding
6th Nov 20188:24 amRNSHolding(s) in Company
6th Nov 20187:00 amRNSPDMR Shareholding
2nd Nov 20184:08 pmRNSDividend Declaration
2nd Nov 20187:00 amRNSInterim Results
15th Oct 20187:00 amRNSTrading Update
2nd Oct 20189:09 amRNSHolding(s) in Company
28th Sep 201810:15 amRNSHolding(s) in Company
21st Sep 201811:56 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSAd Ratings and Trading Update
31st Aug 20185:02 pmRNSTotal Voting Rights
20th Aug 20187:00 amRNSHolding(s) in Company
17th Aug 20182:58 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSExercise of Options
26th Jul 20187:00 amRNSDirectorate Change
25th Jul 201812:04 pmRNSResult of AGM
24th Jul 20187:00 amRNSBoard Changes
10th Jul 20189:12 amRNSHolding(s) in Company
9th Jul 201811:31 amRNSHolding(s) in Company
2nd Jul 20183:50 pmRNSAnnual Report and Notice of AGM
28th Jun 20185:57 pmRNSHolding(s) in Company
12th Jun 20187:00 amRNSExercise of Options
11th Jun 20187:00 amRNSBoard Change
5th Jun 20184:31 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSDirector/PDMR Shareholding
4th Jun 20183:10 pmRNSDividend Declaration
1st Jun 20187:00 amRNSFinancial results to 31 March 2018
23rd May 20188:26 amRNSHolding(s) in Company
27th Apr 20184:30 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSTrading Update
9th Mar 20183:30 pmRNSTransaction in Own Shares
9th Mar 20187:00 amRNSExercise of Options and Buyback of Option Shares
8th Jan 20187:00 amRNSTrading Update
28th Nov 201711:52 amRNSHolding(s) in Company
27th Nov 20179:48 amRNSHolding(s) in Company
17th Nov 20177:00 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSInterim Results
16th Oct 20177:00 amRNSTrading Update
2nd Oct 20174:26 pmRNSHolding(s) in Company
12th Sep 20172:31 pmRNSHolding(s) in Company
21st Aug 20175:49 pmRNSHolding(s) in Company
21st Aug 20177:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.